GILD
Gilead Sciences, Inc.
NMS
$127.57
-3.53
(-2.69%)
Pullback · -1.49σ
Quarterly financials
last 6 quarters| Quarter | Revenue | Gross profit | Op income | Net income | Free cash flow | Gross % | Op % | Net % |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $6.96B | $5.51B | $2.69B | $2.02B | $2.43B | 79.2% | 38.7% | 29.0% |
| 2025-12-31 | $7.92B | $6.30B | $2.99B | $2.18B | $3.12B | 79.5% | 37.7% | 27.5% |
| 2025-09-30 | $7.77B | $6.20B | $3.50B | $3.05B | $3.96B | 79.8% | 45.0% | 39.3% |
| 2025-06-30 | $7.08B | $5.58B | $2.72B | $1.96B | $720.0M | 78.8% | 38.5% | 27.7% |
| 2025-03-31 | $6.67B | $5.13B | $2.49B | $1.31B | $1.65B | 76.9% | 37.3% | 19.7% |
| 2024-12-31 | $nan | $nan | $nan | $nan | $nan | nan% | nan% | nan% |